Concept information
Nervous System Diseases
Demyelinating Diseases
Hereditary Central Nervous System Demyelinating Diseases
...
Metabolic Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Hereditary Central Nervous System Demyelinating Diseases
...
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Hereditary Central Nervous System Demyelinating Diseases
...
Genetic Diseases, Inborn
Metabolism, Inborn Errors
Brain Diseases, Metabolic, Inborn
Hereditary Central Nervous System Demyelinating Diseases
...
Metabolic Diseases
Metabolism, Inborn Errors
Brain Diseases, Metabolic, Inborn
Hereditary Central Nervous System Demyelinating Diseases
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Hereditary Central Nervous System Demyelinating Diseases
Preferred term
Canavan Disease
Type
-
mesh:Descriptor
Definition
- A rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demeylination that gives rise to a spongy appearance. Aspartoacylase deficiency leads to an accumulation of N-acetylaspartate in astrocytes. Inheritance may be autosomal recessive or the illness may occur sporadically. This illness occurs more frequently in individuals of Ashkenazic Jewish descent. The neonatal form features the onset of hypotonia and lethargy at birth, rapidly progressing to coma and death. The infantile form features developmental delay, DYSKINESIAS, hypotonia, spasticity, blindness, and megalencephaly. The juvenile form is characterized by ATAXIA; OPTIC ATROPHY; and DEMENTIA. (From Adams et al., Principles of Neurology, 6th ed, p944; Am J Med Genet 1988 Feb;29(2):463-71)
Broader concept
Entry terms
- Canavan-van Bogaert-Bertrand Disease
- Leukodystrophy, Spongiform
- Spongy Degeneration Of Central Nervous System
- Spongy Degeneration of Infancy
- Spongy Degeneration of the Brain
- Spongy Degeneration of the Central Nervous System
- Spongy Degeneration of White Matter In Infancy
- Spongy Disease of Central Nervous System
- Spongy Disease of White Matter
- Van Bogaert-Bertrand Syndrome
- Von Bogaert-Bertrand Disease
Allowable Qualifier(s)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemically induced (Qualifier)
- classification (Qualifier)
- complications (Qualifier)
- diagnosis (Qualifier)
- diagnostic imaging (Qualifier)
- diet therapy (Qualifier)
- drug therapy (Qualifier)
- economics (Qualifier)
- embryology (Qualifier)
- enzymology (Qualifier)
- epidemiology (Qualifier)
- ethnology (Qualifier)
- etiology (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- metabolism (Qualifier)
- microbiology (Qualifier)
- mortality (Qualifier)
- nursing (Qualifier)
- parasitology (Qualifier)
- pathology (Qualifier)
- physiopathology (Qualifier)
- prevention & control (Qualifier)
- psychology (Qualifier)
- radiotherapy (Qualifier)
- rehabilitation (Qualifier)
- surgery (Qualifier)
- therapy (Qualifier)
- urine (Qualifier)
- veterinary (Qualifier)
- virology (Qualifier)
In other languages
-
French
-
Déficit en aspartoacylase
-
Dégénérescence spongieuse du système nerveux central
-
Maladie de Canavan-von Bogaërt
URI
http://data.loterre.fr/ark:/67375/JVR-WD8XP421-8
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}